key: cord-0903333-qqwr5ew4 authors: Patlolla, Sri Harsha; Sundaragiri, Pranathi R.; Cheungpasitporn, Wisit; Doshi, Rajkumar; Vallabhajosyula, Saraschandra title: Impact of concomitant respiratory infections in the management and outcomes acute myocardial infarction-cardiogenic shock date: 2021-07-17 journal: Indian Heart J DOI: 10.1016/j.ihj.2021.07.004 sha: 423599da3c8a85b1b82df42373820e7836ff1d26 doc_id: 903333 cord_uid: qqwr5ew4 OBJECTIVE: To evaluate the prevalence and impact of respiratory infections in cardiogenic shock complicating acute myocardial infarction (AMI-CS). METHODS: Using the National Inpatient Sample (2000–2017), this study identified adult (≥18 years) admitted with AMI-CS complicated by respiratory infections. Outcomes of interest included in-hospital mortality of AMI-CS admissions with and without respiratory infections, hospitalization costs, hospital length of stay, and discharge disposition. Temporal trends of prevalence, in-hospital mortality and cardiac procedures were evaluated. RESULTS: Among 557,974 AMI-CS admissions, concomitant respiratory infections were identified in 84,684 (15.2%). Temporal trends revealed a relatively stable trend in prevalence of respiratory infections over the 18-year period. Admissions with respiratory infections were on average older, less likely to be female, with greater comorbidity, had significantly higher rates of NSTEMI presentation, and acute non-cardiac organ failure compared to those without respiratory infections (all p < 0.001). These admissions received lower rates of coronary angiography (66.8% vs 69.4%, p < 0.001) and percutaneous coronary interventions (44.8% vs 49.5%, p < 0.001), with higher rates of mechanical circulatory support, pulmonary artery catheterization, and invasive mechanical ventilation compared to AMI-CS admissions without respiratory infections (all p < 0.001). The in-hospital mortality was lower among AMI-CS admissions with respiratory infections (31.6% vs 38.4%, adjusted OR 0.58 [95% CI 0.57–0.59], p < 0.001). Admissions with respiratory infections had longer lengths of hospital stay (127, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 vs 63, 4, 5, 6, 7, 8, 9, 10, 11 days, p < 0.001), higher hospitalization costs and less frequent discharges to home (27.1% vs 44.7%, p < 0.001). CONCLUSIONS: Respiratory infections in AMI-CS admissions were associated with higher resource utilization but lower in-hospital mortality. Despite increase in early revascularization with percutaneous coronary interventions (PCI), acute myocardial infarction with cardiogenic shock (AMI-CS) continues to be associated with high inpatient mortality of around 30e45%. 1 Patients with AMI-CS have associated hemodynamic instability, fluid overload, and respiratory compromise with a greater need for mechanical circulatory support (MCS), invasive therapies, and mechanical ventilation. 2, 3 However, these management strategies confer risk of infections in these patients. 4, 5 In addition to ventilator-associated respiratory infections, the use of cardiopulmonary resuscitation and hypothermia in these critically ill patients further increases risk of infections like pneumonia. 5, 6 The inflammatory and immune response due to respiratory infections has been shown to have a role in pathogenesis of acute cardiovascular events including AMI. 7, 8 The recent COVID-19 pandemic has shown a similar cardiac dysfunction together with inflammatory state resulting in cardiogenic and vasodilatory shock. 9 Available data have shown increased in-hospital mortality due to pneumonia and influenza in patients with AMI. 8, 10, 11 However, no accurate data is reported on the role of concomitant pneumonia and influenza in patients with AMI-CS. Hence, using a large national database, we sought to assess the prevalence and impact of these respiratory infections on outcomes in AMI-CS. We also sought to evaluate the demographics, clinical characteristics, management strategies and resource utilization of AMI-CS stratified by the presence of respiratory infections to better inform clinical care for these patients. The National (Nationwide) Inpatient Sample (NIS) contains discharge data from a 20% stratified sample of community hospitals and is the largest all-payer database of hospital inpatient stays in the United States. It is a part of the Healthcare Quality and Utilization Project (HCUP), sponsored by the Agency for Healthcare Research and Quality. 12 The HCUP-NIS does not capture individual patients but captures all information for a given admission. Information regarding each discharge includes patient demographics, primary payer, hospital characteristics, principal diagnosis, up to 29 secondary diagnoses, and procedural diagnoses. Institutional Review Board approval was not sought due to the publicly available nature of this de-identified database. These data are available to other authors via the HCUP-NIS database with the Agency for Healthcare Research and Quality. 12 Using the HCUP-NIS data from January 1, 2000 through December 31, 2017, a retrospective cohort of adult admissions (>18 years) with AMI in the primary diagnosis field (International Classification of Diseases 9.0 Clinical Modification [ICD-9CM] 410. x and ICD-10 CM I21. x-22. x) and a secondary diagnosis of CS (ICD-9 CM 785.51, ICD-10 CM R57.0) were identified. 1, 13, 14 The administrative codes for CS have been noted to have high positive predictive value (>90%) and specificity (>95%) but low sensitivity (>50%). 15, 16 Concomitant respiratory infections including pneumococcal and other bacterial pneumonia, interstitial pneumonia due to organisms like mycoplasma and chlamydia, unspecified pneumonia, influenza due to avian virus, H1n1 and novel influenza A virus were all identified using ICD-9 CM 481e488 and ICD-10 CM J09-18. The Deyo's modification of the Charlson Comorbidity Index was used to identify the burden of co-morbid diseases. 17 The admissions month was used to identify the season of admission. Similar to prior literature, we defined the seasons based on the meteorological classification of the Northern Hemisphere aseSpring (MarcheMay), Summer (JuneeAugust), Fall (Septem-bereNovember) and Winter (December-February). 18, 19 Chronic lung disease was identified using Charlson Comorbidity Index codes ICD-9CM 416.8, 416.9, 490. x-505. x, 506.4, 508.1, 508.8 and ICD-10 CM I27.8, I27.9, J40. x-J47. x, J60. x-J67. x, J68.4, J70.1, J70.3. Demographic characteristics including age, sex, race, hospital characteristics, acute organ failure, MCS, cardiac procedures, and non-cardiac organ support therapies were identified for all admissions using previously used methodologies from our group (Supplementary Table 1 ). 1e3, 13,14,19e35 The primary outcome of interest was differences in the inhospital mortality of AMI-CS admissions with and without respiratory infections. The secondary outcomes included use of coronary angiography, PCI, MCS, hospitalization costs, hospital length of stay, and discharge disposition. Sub-group analyses were performed to confirm the results of the primary analysis stratifying the population by age (